EGF and early-onset autosomal dominant Alzheimer disease: Lim et al. showed that low plasma EGF levels correlated with cognitive decline in Alzheimer's disease and Parkinson's Disease patients, suggesting EGF as a biomarker for cognitive decline (Lim et al., 2016).